» Authors » Sebastien Moniot

Sebastien Moniot

Explore the profile of Sebastien Moniot including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 840
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Sundriyal S, Moniot S, Mahmud Z, Yao S, Di Fruscia P, Reynolds C, et al.
J Med Chem . 2017 Jan; 60(5):1928-1945. PMID: 28135086
Sirtuins (SIRTs) are NAD-dependent deacylases, known to be involved in a variety of pathophysiological processes and thus remain promising therapeutic targets for further validation. Previously, we reported a novel thienopyrimidinone...
12.
Quinti L, Casale M, Moniot S, Pais T, Van Kanegan M, Kaltenbach L, et al.
Cell Chem Biol . 2016 Jul; 23(7):849-861. PMID: 27427231
There are currently no disease-modifying therapies for the neurodegenerative disorder Huntington's disease (HD). This study identified novel thiazole-containing inhibitors of the deacetylase sirtuin-2 (SIRT2) with neuroprotective activity in ex vivo...
13.
Valente S, Mellini P, Spallotta F, Carafa V, Nebbioso A, Polletta L, et al.
J Med Chem . 2015 Dec; 59(4):1471-91. PMID: 26689352
Modulators of sirtuins are considered promising therapeutic targets for the treatment of cancer, cardiovascular, metabolic, inflammatory, and neurodegenerative diseases. Here we prepared new 1,4-dihydropyridines (DHPs) bearing changes at the C2/C6,...
14.
Chen X, Wales P, Quinti L, Zuo F, Moniot S, Herisson F, et al.
PLoS One . 2015 Jan; 10(1):e0116919. PMID: 25608039
Sirtuin deacetylases regulate diverse cellular pathways and influence disease processes. Our previous studies identified the brain-enriched sirtuin-2 (SIRT2) deacetylase as a potential drug target to counteract neurodegeneration. In the present...
15.
Di Fruscia P, Zacharioudakis E, Liu C, Moniot S, Laohasinnarong S, Khongkow M, et al.
ChemMedChem . 2014 Nov; 10(1):69-82. PMID: 25395356
Sirtuins, NAD(+) -dependent histone deacetylases (HDACs), have recently emerged as potential therapeutic targets for the treatment of a variety of diseases. The discovery of potent and isoform-selective inhibitors of this...
16.
Kleinboelting S, Diaz A, Moniot S, van den Heuvel J, Weyand M, Levin L, et al.
Proc Natl Acad Sci U S A . 2014 Feb; 111(10):3727-32. PMID: 24567411
cAMP is an evolutionary conserved, prototypic second messenger regulating numerous cellular functions. In mammals, cAMP is synthesized by one of 10 homologous adenylyl cyclases (ACs): nine transmembrane enzymes and one...
17.
Lakshminarasimhan M, Curth U, Moniot S, Mosalaganti S, Raunser S, Steegborn C
Biosci Rep . 2013 Apr; 33(3). PMID: 23548308
Sirtuins are NAD+-dependent protein deacetylases regulating metabolism, stress responses and ageing processes. Among the seven mammalian Sirtuins, Sirt1 is the physiologically best-studied isoform. It regulates nuclear functions such as chromatin...
18.
Moniot S, Schutkowski M, Steegborn C
J Struct Biol . 2013 Mar; 182(2):136-43. PMID: 23454361
Sirtuins are NAD(+)-dependent protein deacetylases that regulate metabolism and aging-related processes. Sirt2 is the only cytoplasmic isoform among the seven mamalian Sirtuins (Sirt1-7) and structural information concerning this isoform is...
19.
Xu N, Yu S, Moniot S, Weyand M, Blankenfeldt W
Acta Crystallogr Sect F Struct Biol Cryst Commun . 2012 Sep; 68(Pt 9):1034-9. PMID: 22949189
The opportunistic bacterial pathogen Pseudomonas aeruginosa employs three transcriptional regulators, LasR, RhlR and PqsR, to control the transcription of a large subset of its genes in a cell-density-dependent process known...
20.
Moniot S, Weyand M, Steegborn C
Front Pharmacol . 2012 Feb; 3:16. PMID: 22363286
Sirtuins are NAD(+)-dependent protein deacetylases regulating metabolism, stress responses, and aging processes. Mammalia have seven Sirtuin isoforms, Sirt1-7, which differ in their substrate specificities and subcellular localizations. The physiological functions...